
Robert A. Zeman
Examiner (ID: 12430, Phone: (571)272-0866 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645, 1643 |
| Total Applications | 1326 |
| Issued Applications | 557 |
| Pending Applications | 268 |
| Abandoned Applications | 538 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18091336
[patent_doc_number] => 20220409677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => NOVEL PROBIOTIC COMPOSITION FOR REGULATION OF INTESTINAL IMMUNITY
[patent_app_type] => utility
[patent_app_number] => 17/622177
[patent_app_country] => US
[patent_app_date] => 2019-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9748
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17622177
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/622177 | NOVEL PROBIOTIC COMPOSITION FOR REGULATION OF INTESTINAL IMMUNITY | Jul 22, 2019 | Abandoned |
Array
(
[id] => 15035709
[patent_doc_number] => 20190328859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => CLOSTRIDIUM DIFFICILE ANTIGENS
[patent_app_type] => utility
[patent_app_number] => 16/511503
[patent_app_country] => US
[patent_app_date] => 2019-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18613
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 218
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16511503
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/511503 | CLOSTRIDIUM DIFFICILE ANTIGENS | Jul 14, 2019 | Abandoned |
Array
(
[id] => 15321057
[patent_doc_number] => 20200000858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => COMPOSITIONS COMPRISING BACTERIAL STRAINS
[patent_app_type] => utility
[patent_app_number] => 16/504980
[patent_app_country] => US
[patent_app_date] => 2019-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15568
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16504980
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/504980 | COMPOSITIONS COMPRISING BACTERIAL STRAINS | Jul 7, 2019 | Abandoned |
Array
(
[id] => 15852991
[patent_doc_number] => 10641769
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-05-05
[patent_title] => Rapid analysis for cyanobacterial toxins
[patent_app_type] => utility
[patent_app_number] => 16/433424
[patent_app_country] => US
[patent_app_date] => 2019-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 11975
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16433424
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/433424 | Rapid analysis for cyanobacterial toxins | Jun 5, 2019 | Issued |
Array
(
[id] => 16913997
[patent_doc_number] => 20210187089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => Malaria pre-erythrocytic antigens as a fusion polypeptide and their use in the elicitation of a protective immune response in a host
[patent_app_type] => utility
[patent_app_number] => 17/057095
[patent_app_country] => US
[patent_app_date] => 2019-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28837
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 214
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17057095
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/057095 | Malaria pre-erythrocytic antigens as a fusion polypeptide and their use in the elicitation of a protective immune response in a host | May 22, 2019 | Issued |
Array
(
[id] => 18202400
[patent_doc_number] => 11584782
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-21
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 16/404374
[patent_app_country] => US
[patent_app_date] => 2019-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 44
[patent_no_of_words] => 14899
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16404374
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/404374 | None | May 5, 2019 | Issued |
Array
(
[id] => 16883805
[patent_doc_number] => 20210170000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => Larval preparation of Heligmosomoides polygyrus bakeri as well as methods of making it and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/044932
[patent_app_country] => US
[patent_app_date] => 2019-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19426
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17044932
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/044932 | Larval preparation of Heligmosomoides polygyrus bakeri as well as methods of making it and uses thereof | Apr 4, 2019 | Pending |
Array
(
[id] => 14564079
[patent_doc_number] => 20190209646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => BACTERIAL INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/363908
[patent_app_country] => US
[patent_app_date] => 2019-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20371
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16363908
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/363908 | Bacterial inhibitors | Mar 24, 2019 | Issued |
Array
(
[id] => 16598409
[patent_doc_number] => 20210024940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => RECOMBINANT THERAPEUTIC INTERVENTIONS FOR CANCER
[patent_app_type] => utility
[patent_app_number] => 16/638943
[patent_app_country] => US
[patent_app_date] => 2019-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24929
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16638943
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/638943 | RECOMBINANT THERAPEUTIC INTERVENTIONS FOR CANCER | Mar 13, 2019 | Pending |
Array
(
[id] => 16655326
[patent_doc_number] => 20210051962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => USES OF CYANOBACTERIUM EXTRACELLULAR POLYMER, COMPOSITIONS, COATED SURFACES OR ARTICLES
[patent_app_type] => utility
[patent_app_number] => 16/979045
[patent_app_country] => US
[patent_app_date] => 2019-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6449
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16979045
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/979045 | USES OF CYANOBACTERIUM EXTRACELLULAR POLYMER, COMPOSITIONS, COATED SURFACES OR ARTICLES | Mar 7, 2019 | Abandoned |
Array
(
[id] => 16539428
[patent_doc_number] => 20200405841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => Immunogenic Composition
[patent_app_type] => utility
[patent_app_number] => 16/978870
[patent_app_country] => US
[patent_app_date] => 2019-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24702
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16978870
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/978870 | Immunogenic Composition | Mar 5, 2019 | Abandoned |
Array
(
[id] => 18389864
[patent_doc_number] => 20230158082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => NANOVESICLES DERIVED FROM COPROCOCCUS SP. BACTERIA, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/977692
[patent_app_country] => US
[patent_app_date] => 2019-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7292
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16977692
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/977692 | NANOVESICLES DERIVED FROM COPROCOCCUS SP. BACTERIA, AND USE THEREOF | Mar 4, 2019 | Abandoned |
Array
(
[id] => 17350005
[patent_doc_number] => 11224623
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-18
[patent_title] => Agent for inducing interferon production containing lactic acid bacteria
[patent_app_type] => utility
[patent_app_number] => 16/290581
[patent_app_country] => US
[patent_app_date] => 2019-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 51
[patent_no_of_words] => 13822
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16290581
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/290581 | Agent for inducing interferon production containing lactic acid bacteria | Feb 28, 2019 | Issued |
Array
(
[id] => 16539393
[patent_doc_number] => 20200405806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => COMBINATION OF A TETANUS TOXOID, ANTI-OX40 ANTIBODY AND/OR ANTI-PD-1 ANTIBODY TO TREAT TUMORS
[patent_app_type] => utility
[patent_app_number] => 16/968507
[patent_app_country] => US
[patent_app_date] => 2019-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19161
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16968507
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/968507 | COMBINATION OF A TETANUS TOXOID, ANTI-OX40 ANTIBODY AND/OR ANTI-PD-1 ANTIBODY TO TREAT TUMORS | Feb 6, 2019 | Abandoned |
Array
(
[id] => 15145019
[patent_doc_number] => 20190350987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING CANCER AND IMMUNE DISORDERS USING VEILLONELLA BACTERIA
[patent_app_type] => utility
[patent_app_number] => 16/268745
[patent_app_country] => US
[patent_app_date] => 2019-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45823
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16268745
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/268745 | Compositions and methods for treating cancer and immune disorders using | Feb 5, 2019 | Issued |
Array
(
[id] => 16620010
[patent_doc_number] => 20210038663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => FECAL FUNGOME AND THERAPEUTIC EFFICACY OF FECAL MICROBIOTA TRANSPLANTATION
[patent_app_type] => utility
[patent_app_number] => 16/966853
[patent_app_country] => US
[patent_app_date] => 2019-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18362
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16966853
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/966853 | FECAL FUNGOME AND THERAPEUTIC EFFICACY OF FECAL MICROBIOTA TRANSPLANTATION | Jan 31, 2019 | Abandoned |
Array
(
[id] => 14338815
[patent_doc_number] => 20190151380
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => COMPOSITIONS COMPRISING BACTERIAL STRAINS
[patent_app_type] => utility
[patent_app_number] => 16/265238
[patent_app_country] => US
[patent_app_date] => 2019-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22914
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16265238
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/265238 | Compositions comprising bacterial strains | Jan 31, 2019 | Issued |
Array
(
[id] => 17272926
[patent_doc_number] => 20210379124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => Prophylactic and/or Therapeutic Agents for Streptococcus Pneumoniae Infection
[patent_app_type] => utility
[patent_app_number] => 16/962921
[patent_app_country] => US
[patent_app_date] => 2019-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6723
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16962921
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/962921 | Prophylactic and/or therapeutic agents for | Jan 30, 2019 | Issued |
Array
(
[id] => 16310850
[patent_doc_number] => 20200289588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => BIFIDOBACTERIUM LONGUM NCIMB 41676
[patent_app_type] => utility
[patent_app_number] => 16/767901
[patent_app_country] => US
[patent_app_date] => 2019-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8097
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16767901
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/767901 | BIFIDOBACTERIUM LONGUM NCIMB 41676 | Jan 28, 2019 | Abandoned |
Array
(
[id] => 18013316
[patent_doc_number] => 11505598
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-22
[patent_title] => Antibodies to botulinum neurotoxins
[patent_app_type] => utility
[patent_app_number] => 16/259418
[patent_app_country] => US
[patent_app_date] => 2019-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 5
[patent_no_of_words] => 33575
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 173
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16259418
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/259418 | Antibodies to botulinum neurotoxins | Jan 27, 2019 | Issued |